These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 35761846)

  • 1. Clinical Epidemiology, Treatment Outcome and Mortality Rate of Newly Diagnosed Immune Thrombocytopenia in Adult Multicentre Study in Malaysia.
    Hamzah R; Yusof N; Tumian NR; Abdul Aziz S; Mohammad Basri NS; Leong TS; Ho KW; Selvaratnam V; Tan SM; Muhamad Jamil SA
    J Blood Med; 2022; 13():337-349. PubMed ID: 35761846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newly diagnosed immune thrombocytopenia adults: Clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohort.
    Moulis G; Germain J; Comont T; Brun N; Dingremont C; Castel B; Arista S; Sailler L; Lapeyre-Mestre M; Beyne-Rauzy O; Godeau B; Adoue D;
    Am J Hematol; 2017 Jun; 92(6):493-500. PubMed ID: 28240787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment patterns of thrombopoietin receptor agonists among adults with primary immune thrombocytopenia: A Korean nationwide population-based study.
    Lee JY; Lee JH; Kim SA; Suh KJ; Kim JW; Kim SH; Lee JO; Kim JW; Kim YJ; Lee KW; Kim JH; Lee JS; Bang SM
    Thromb Res; 2022 May; 213():114-118. PubMed ID: 35334441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and safety of romiplostim among patients with newly diagnosed, persistent and chronic ITP in routine clinical practice in central and Eastern Europe: an analysis of the PLATON study.
    Skopec B; Sninska Z; Tzvetkov N; Ivanushkin V; Björklöf K; Hippenmeyer J; Mihaylov G
    Hematology; 2021 Dec; 26(1):497-502. PubMed ID: 34238136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment-free remission after thrombopoietin receptor agonist discontinuation in patients with newly diagnosed immune thrombocytopenia: an observational retrospective analysis in real-world clinical practice.
    Iino M; Sakamoto Y; Sato T
    Int J Hematol; 2020 Aug; 112(2):159-168. PubMed ID: 32476083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
    Kolonić SO; Patekar MB; Milunović V
    Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Romiplostim for the Treatment of Immune Thrombocytopenia: Spotlight on Patient Acceptability and Ease of Use.
    Gilbert MM; Grimes AB; Kim TO; Despotovic JM
    Patient Prefer Adherence; 2020; 14():1237-1250. PubMed ID: 32801654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The burden of immune thrombocytopenia in adults: evaluation of the thrombopoietin receptor agonist romiplostim.
    Deuson R; Danese M; Mathias SD; Schoonen M; Fryzek J
    J Med Econ; 2012; 15(5):956-76. PubMed ID: 22533524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.
    Zaja F; Barcellini W; Cantoni S; Carpenedo M; Caparrotti G; Carrai V; Di Renzo N; Santoro C; Di Nicola M; Veneri D; Simonetti F; Liberati AM; Ferla V; Paoloni F; Crea E; Volpetti S; Tuniz E; Fanin R
    Am J Hematol; 2016 May; 91(5):E293-5. PubMed ID: 26910388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Epidemiology Study of Adult Immune Thrombocytopenia Patients in a Teaching Hospital in Northeastern Malaysia.
    Zahidin MA; Abdul Razak NI; Mohd Noor NH; Johan MF; Zulkafli Z; Abdullah AD; Edinur HA
    Cureus; 2023 Nov; 15(11):e48533. PubMed ID: 38073971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review.
    Bhattacharjee S; Banerjee M
    SN Compr Clin Med; 2020; 2(11):2048-2058. PubMed ID: 32984764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical Practice.
    Snell Taylor SJ; Nielson CM; Breskin A; Saul B; Yu Y; Alam N; Eisen M; Hippenmeyer J; Janssens A; Kozak T; Papadaki HA; Selleslag D; Viallard JF; Feistritzer C; Kaiafa G; Kelsh M; Kilpatrick K; Brookhart MA; McGrath LJ
    Adv Ther; 2021 May; 38(5):2673-2688. PubMed ID: 33866516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of primary immune thrombocytopenia in children and adults in Japan: a population-based study and literature review.
    Kurata Y; Fujimura K; Kuwana M; Tomiyama Y; Murata M
    Int J Hematol; 2011 Mar; 93(3):329-335. PubMed ID: 21347644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiology, disease presentation and course of idiopathic thrombocytopenic purpura in Danish children from 1998-2000].
    Kjaersgaard M; Edslev PW; Rosthøj S
    Ugeskr Laeger; 2008 May; 170(22):1922-6. PubMed ID: 18513475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in Diagnosis and Treatments for Immune Thrombocytopenia.
    Nomura S
    Clin Med Insights Blood Disord; 2016; 9():15-22. PubMed ID: 27441004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, Treatment Patterns, and Cost Analysis of Immune Thrombocytopenia in Spain between 2014 and 2020: A Population-based Study.
    González-López TJ; Alperovich G; Burillo E; Espejo-Saavedra Soler M; Rebollo-Gómez E; Hernández I; Justicia JL; Lozano ML
    TH Open; 2024 Jul; 8(3):e252-e265. PubMed ID: 38983689
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombopoietin receptor agonists and rituximab for treatment of pediatric immune thrombocytopenia: A systematic review and meta-analysis of prospective clinical trials.
    Ayad N; Grace RF; Al-Samkari H
    Pediatr Blood Cancer; 2022 Mar; 69(3):e29447. PubMed ID: 34962697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiology and pharmacoepidemiology of immune thrombocytopenia].
    Moulis G; Lapeyre-Mestre M; Adoue D; Sailler L
    Rev Med Interne; 2017 Jul; 38(7):444-449. PubMed ID: 28131440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controversies in the treatment of immune thrombocytopenia.
    Cuker A; Cines DB; Neunert CE
    Curr Opin Hematol; 2016 Sep; 23(5):479-85. PubMed ID: 27380558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment characteristics, efficacy and safety of thrombopoietin analogues in routine management of primary immune thrombocytopenia.
    Mingot-Castellano ME; Caparrós IS; Fernández F; Perera-Alvarez MDM; Jimenez-Bárcenas R; Casaus García A; González-Silva M; Yera-Cobo M; Nieto-Hernandez MM; Rodríguez-Fernandez MJ; Díaz-Canales D
    Blood Coagul Fibrinolysis; 2018 Jun; 29(4):374-380. PubMed ID: 29738335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.